-
Baseline characteristics of the population enrolled to a randomized clinical study of subcutaneous levodopa/carbidopa (ND0612) infusion in patients with advanced PD
-
Baseline Clinical Predictors of Future Psychotic Symptoms in de novo Parkinson Disease
-
Baseline multimodal information predicts future motor impairment in premanifest Huntington’s disease
-
Baseline predictors for clinical progression after 48 month follow-up in early Parkinson’s disease from the DeNoPa cohort
-
Baseline risk factors of insomnia symptoms after five years of follow-up: a population-based cohort of incident Parkinson’s disease
-
Battery consumption and need for replacement in patients with Parkinson disease treated with interleaved deep brain stimulation
-
Behavioral and psychological symptoms in Parkinson’s disease with SWEDDs
-
Behavioral Changes on the UCSD Huntington’s Disease Behavioral Questionnaire (HD-BQ) Distinguish Patients Transitioning to Manifest Huntington’s disease (HD)
-
Beneficial and Protective Effects of Withania Someniferais On Mice Brain: A Therapeutic Potential Drug for Parkinson’s Disease
-
Beta oscillatory changes during practice and retention of motor skills in healthy subjects and patients with PD
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 155
- Next Page »